da Costa Ferreira, S., Parra, R. S., Sassaki, L. Y. [., Parente, J. M. L., de Mello, M. K., Chebli, L. A., . . . Chebli, J. M. F. (2025). Clinical effectiveness and safety of vedolizumab versus infliximab in biologic-naïve patients with ulcerative colitis: A comparative real-world multicentric observational study.
Chicago Style Citationda Costa Ferreira, Sandro, et al. Clinical Effectiveness and Safety of Vedolizumab Versus Infliximab in Biologic-naïve Patients With Ulcerative Colitis: A Comparative Real-world Multicentric Observational Study. 2025.
MLA Citationda Costa Ferreira, Sandro, et al. Clinical Effectiveness and Safety of Vedolizumab Versus Infliximab in Biologic-naïve Patients With Ulcerative Colitis: A Comparative Real-world Multicentric Observational Study. 2025.